← Open Payments lookup

MARY CHAMBERLAIN: Open Payments

NPI 1487112876 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$414 in 18 payments from 8 companies in 2025. Trend: 2023 $24 · 2024 $877 · 2025 $414

Food & beverage: $414
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$129
ABBVIE INC.3$70
Takeda Pharmaceuticals U.S.A., Inc.3$63
Neurocrine BioSciences, Inc.2$58
E.R. Squibb & Sons, L.L.C.1$28
Janssen Pharmaceuticals, Inc1$25
Alkermes, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: UZEDY, VRAYLAR, TRINTELLIX, INGREZZA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, ARISTADA.

Industry payments across CO — which companies pay providers there.